Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Digestive Health Therapeutics is a biotechnology company and a wholly-owned subsidiary of KNOW Bio, LLC, focused on developing nitric oxide-based treatments for gastrointestinal and hepatological conditions. The company utilizes a proprietary nitric oxide powder technology that allows for tunable, localized delivery of nitric oxide to address conditions associated with nitric oxide deficiency. Its research targets a wide range of physiological processes, including the gastrointestinal microbiome, motility, mucosal function, and inflammatory responses. Based in the Research Triangle Park area, the company operates using a leveraged drug development model to advance its pipeline of therapeutically active compounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Digestive Health Therapeutics.